Brii Biosciences introduces BRiSC platform for dual targeting siRNA drugs
October 16, 2026 | 14:39
Biotechnology company Brii Biosciences launched its proprietary BRiSC discovery platform to accelerate development of next-generation dual-targeting small interfering RNA therapeutic candidates.
Mobile Version